DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here
Structuring for Success: Pharma's Multichannel Acceleration

We interviewed pharma’s multichannel leaders to discover the keys to building successful customer engagement teams and capabilities

Clients use Structuring for Success to:

  • Plan/launch/relaunch multichannel capabilities or Centers of Excellence (COE)
  • Identify most successful approaches for structuring multichannel teams
  • Optimize multichannel team roles and channel expertise
  • Gain executive buy-in for multichannel headcount or technology investment
  • Plan for staffing needed to effectively engage customers in 2018+

Get access to:

  • Expert analysts and organizational consultants who work extensively with leading pharma multichannel teams
  • Candid case studies from current and former COE leaders
  • Benchmark org charts for 3 pharma multichannel COEs

Get access to:

  • What challenges and obstacles do we need to plan for? How do other pharma multichannel teams address these challenges?
  • How should we structure our multichannel team? Should we be more closely aligned with brand and treatment area leadership?
  • What are industry best practices for establishing and structuring multichannel centers of excellence?
  • In which areas of expertise should our team invest? Where should we be spending most of our time?
  • How do peers fund and budget their multichannel COEs?
  • What are the most common software platforms and vendors deployed by our peers?
  • What organizational characteristics are associated with COE success?
  • How can we create a 'future-proof' team that will withstand changes in corporate culture and technology?
  • Where should we go from here?